Clinical Cardiology Current Events | Clinical Cardiology News | 7
|
| Page
7 of
16 |
313 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers: Few heart disease trials reporting sex-specific results
Heart disease differences in men and women continue to be poorly understood because women are included in clinical trials far less than men, and even when women are included, study results are not reported by sex. view more (2007-01-31)
Patients with severe psoriasis need evaluation of heart disease risk
According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD). view more (2008-12-18)
ESC Congress 2003: 6 months result of a non-polymeric paclitaxel eluting stent in high-risk lesions
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Hot Line II - Acute coronary syndromes / percutaneous coronary... view more... (2003-09-01)
Cambridge University Press - Greenwich Medical Media Limited
The Syndics of Cambridge University Press are very pleased to announce the acquisition of Greenwich Medical Media Limited (GMM) in a transaction brokered by Bertoli Mitchell. GMM, launched in 1995, have built their reputation on a portfolio of products that includes books, journals and websites. In book publishing they have grown to achieve UK... view more... (2003-12-19)
Dutch study finds four in 10 heart attacks go unrecognised
Dutch researchers who assessed over 4,000 men and women over 55 to see how many heart attacks went undiagnosed at the time they occurred, found that the figure was more than four in 10. view more (2006-02-14)
Major agreement reached at heart health conference
The outlook for the promotion of heart health, across Europe, received a major boost today as consensus was reached at a key health conference, Promoting Heart Health A European Consensus. The Agreement will mean that Europe can potentially reduce the number of people dying from heart disease by 60%. Cardiology and policy advisors from all 25... view more... (2004-02-26)
Study in NEJM: New therapy prevents heart failure
Patients who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD). view more (2009-09-02)
European Society of Cardiology releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)
Sophia Antipolis, France, 22 March 2005: The European Society of Cardiology (ESC) releases the first European Guidelines on Percutaneous Coronary Interventions (PCI), pre-published and accessible on the ESC Web Site(1). According to these Guidelines, PCI can now be regarded as the first option for a larger group of patients with acute coronary... view more... (2005-03-22)
ESC Congress 2004: Diabetes and the heart
The Euro Heart Survey on the diabetic state of patients with coronary artery disease view more (2004-08-30)
Administering stem cells to patients with myocardial infarction leads to a reduction of the infarct
This week, doctors at the Catholic University of Leuven, connected with the University Hospital-Gasthuisberg, the Stem Cell Institute Leuven (SCIL), and the Flanders Interuniversity Institute for Biotechnology (VIB), are publishing a major breakthrough in the treatment of patients with acute myocardial infarction. view more (2006-01-10)
EU to work with ESC on 'Heart Plan for Europe' and strategies
The Council of the European Union (EU) has demonstrated its commitment to European cardiovascular health through its approval of the European Society of Cardiology (ESC) 'Heart Plan for Europe' and the declaration that cardiovascular disease in Europe must be addressed as a 'major priority'. The ESC 'Heart Plan for Europe' was submitted to the EU... view more... (2002-07-23)
Damage inflicted during cardiac attacks more widespread than previously thought, MSU researchers find
Cholesterol crystals released in the bloodstream during a cardiac attack or stroke can damage artery linings much further away from the site of the attack, leaving survivors at greater risk than previously thought. view more (2008-11-12)
ESC Congress 2004: Trial supports early, aggressive statin use after heart attack
Patients suffering from acute coronary syndromes should be treated with cholesterol-lowering drugs known as statins early and aggressively, according to the results of an international clinical trial led by a team of investigators at the Duke Clinical Research Institute, the University of Texas Southwestern Medical Center and the Brigham and... view more... (2004-08-30)
Invitation to the media - Europe`s biggest medical meeting starts this Saturday
The Annual Congress of the European Society of Cardiology is the biggest medical meeting in Europe. ESC 2002 is to be held in Berlin from 31 August - 4 September and will be Germany`s largest conference ever. More than 23,000 attendees are expected to attend ESC 2002, where the highlights include more than 2,000 presentations and an exhibition... view more... (2002-08-26)
Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease
Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease. view more (2008-11-26)
Novel biomarkers in heart failure
Several new biomarkers have been recently described in Heart Failure (HF) syndrome either in stable chronic patients as in the settings of acute decompensation. view more (2009-06-01)
NO BENEFIT FROM USE OF ABCIXIMAB FOR TREATMENT OF ACUTE CORONARY SYNDROMES (pp 1899, 1915)
Results of the GUSTO IV study - published in this week's issue of THE LANCET - unexpectedly suggest that the glycoprotein IIb/IIIa inhibitor abciximab is not an appropriate treatment for patients with acute coronary syndromes (ACS) who are not undergoing revascularisation therapy. Glycoprotein IIb/IIIa blockers reduce procedure-related thrombotic... view more... (2001-06-13)
KNOWLEDGE AND SKILLS OF CLINICAL PHARMACOLOGISTS CURRENTLY UNDERUSED, SAYS REPORT
Key recommendations from the report view more (1999-05-19)
Despite No Gender Difference in Adverse Drug Reactions, Women are Treated Less Frequently than Men with Statins, Aspirin and Beta- Blockers
Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center. view more (2008-03-05)
Percutaneous valve therapy: is it safe and effective?
Researchers at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), will present new studies evaluating a rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves. view more (2007-10-24)
|
|
| Page
7 of
16 |
313 Results |
|
|
|
Sort By:
Page Views | Date |
|
